Which patients with metastatic breast cancer benefit from subsequent lines of treatment? An update for clinicians

by Palumbo, Raffaella, Sottotetti, Federico, Riccardi, Alberto, Teragni, Cristina, Pozzi, Emma, Quaquarini, Erica, Tagliaferri, Barbara, Bernardo, Antonio
Published 2013

Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as second-line chemotherapy in HER2-negative, taxane-pretreated metastatic breast cancer patients: prospective evaluation of...

by Palumbo, Raffaella, Sottotetti, Federico, Trifirò, Giuseppe, Piazza, Elena, Ferzi, Antonella, Gambaro, Anna, Spinapolice, Elena Giulia, Pozzi, Emma, Tagliaferri, Barbara, Teragni, Cristina, Bernardo, Antonio
Published in Drug Des Devel Ther (2015)

Patterns of Care and Clinical Outcomes of First-Line Trastuzumab-Based Therapy in HER2-Positive Metastatic Breast Cancer Patients Relapsing After (Neo)Adjuvant Trastuzumab: An Ital...

by Lambertini, Matteo, Ferreira, Arlindo R., Poggio, Francesca, Puglisi, Fabio, Bernardo, Antonio, Montemurro, Filippo, Poletto, Elena, Pozzi, Emma, Rossi, Valentina, Risi, Emanuela, Lai, Antonella, Zanardi, Elisa, Sini, Valentina, Ziliani, Serena, Minuti, Gabriele, Mura, Silvia, Grasso, Donatella, Fontana, Andrea, Del Mastro, Lucia
Published in Oncologist (2015)